ClinicalTrials.Veeva

Menu

Understanding Factors in Decision Making for Children with Medical Complexity

Utah System of Higher Education (USHE) logo

Utah System of Higher Education (USHE)

Status

Completed

Conditions

Multiple Chronic Conditions
Children with Medical Complexity

Treatments

Behavioral: Ambiguity
Behavioral: Normalizing language
Behavioral: Narrative
Behavioral: Complexity

Study type

Interventional

Funder types

Other

Identifiers

NCT05913206
00154724

Details and patient eligibility

About

The goal of this clinical trial is to compare different strategies to communicate around potential risks and benefits related to treatment decision making in parents/adult caregivers of children with medical complexity. The objective of this study is to identify the most effective ways to communicate decision-related risks and benefits to improve the quality of caregiver decision making for children with medical complexity.

Participants will view a video of a simulated clinic visit and related medical information and complete a survey about their experiences. Researchers will compare participant survey responses to see if decision quality changes based on the information reviewed by the participant.

Full description

Children with medical complexity, their caregivers, and their providers face a multitude of complex, high stakes medical decisions throughout their lifetime. Best practices for the provision of high quality shared decision making in the care of children with medical complexity do not exist. Unique challenges to support decision making for caregivers of children with medical complexity include communication of decision-related risks and benefits and knowledge related to the decision. This study will test the efficacy of various communication techniques in the setting of a simulated patient encounter.

Enrollment

826 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult caregiver of a child with medical complexity
  • English- or Spanish-speaking

Exclusion criteria

  • Child is diagnosed with neuromuscular scoliosis but has not yet made a decision about whether to undergo spinal fusion.

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Double Blind

826 participants in 16 patient groups

Control
No Intervention group
Description:
No new communication approaches received.
Ambiguity only
Experimental group
Description:
Receive information about ambiguity related to the clinical decision.
Treatment:
Behavioral: Ambiguity
Ambiguity and complexity only
Experimental group
Description:
Receive information about ambiguity and complexity related to the clinical decision.
Treatment:
Behavioral: Complexity
Behavioral: Ambiguity
Ambiguity and normalizing only
Experimental group
Description:
Receive information about ambiguity and normalizing language related to the clinical decision.
Treatment:
Behavioral: Normalizing language
Behavioral: Ambiguity
Ambiguity, complexity, and normalizing only
Experimental group
Description:
Receive information about ambiguity, complexity, and normalizing language related to the clinical decision.
Treatment:
Behavioral: Complexity
Behavioral: Normalizing language
Behavioral: Ambiguity
Complexity only
Experimental group
Description:
Receive information about complexity related to the clinical decision.
Treatment:
Behavioral: Complexity
Complexity and normalizing only
Experimental group
Description:
Receive information about complexity and normalizing language related to the clinical decision.
Treatment:
Behavioral: Complexity
Behavioral: Normalizing language
Normalizing only
Experimental group
Description:
Receive information about normalizing language related to the clinical decision.
Treatment:
Behavioral: Normalizing language
Narratives only
Experimental group
Description:
Receive narratives in addition to the control condition.
Treatment:
Behavioral: Narrative
Ambiguity and narratives only
Experimental group
Description:
Receive information about ambiguity and narratives related to the clinical decision.
Treatment:
Behavioral: Narrative
Behavioral: Ambiguity
Ambiguity, complexity, and narratives only
Experimental group
Description:
Receive information about ambiguity, complexity, and narratives related to the clinical decision.
Treatment:
Behavioral: Narrative
Behavioral: Complexity
Behavioral: Ambiguity
Ambiguity, normalizing, and narratives only
Experimental group
Description:
Receive information about ambiguity, normalizing language, and narratives related to the clinical decision.
Treatment:
Behavioral: Narrative
Behavioral: Normalizing language
Behavioral: Ambiguity
All
Experimental group
Description:
Receive all new communication approaches
Treatment:
Behavioral: Narrative
Behavioral: Complexity
Behavioral: Normalizing language
Behavioral: Ambiguity
Complexity and narratives only
Experimental group
Description:
Receive information about complexity and narratives related to the clinical decision.
Treatment:
Behavioral: Narrative
Behavioral: Complexity
Complexity, normalizing, and narratives only
Experimental group
Description:
Receive information about complexity, normalizing language, and narratives related to the clinical decision.
Treatment:
Behavioral: Narrative
Behavioral: Complexity
Behavioral: Normalizing language
Normalizing and narratives only
Experimental group
Description:
Receive information about normalizing language and narratives related to the clinical decision.
Treatment:
Behavioral: Narrative
Behavioral: Normalizing language

Trial contacts and locations

2

Loading...

Central trial contact

Angela Zhu; Michelle Wilcox

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems